Astellas Pharma
Kuni Itoh serves as a Senior Manager in Corporate Strategy at アステラス製薬 since April 2008, specializing in portfolio, partnering, and R&D strategy, including the evaluation of in-licensing and M&A opportunities. Responsibilities encompass extensive pharmaceutical due diligence, scientific and market competitiveness assessments, and financial evaluations involving various analytical methods. Kuni has also contributed to R&D strategy for cell and gene therapy, regenerative medicine, and infectious diseases, while managing relationships with CMO/CRO globally and preparing regulatory submissions across multiple regions. Currently, Kuni holds a position as a Project Researcher at 東京大学 and serves on the Editorial Committee of the "Bioscience and Industry" magazine for the Japan Bioindustry Association. Educational qualifications include a PhD in Science from The University of Tokyo and a Master’s and Bachelor’s degree in Applied Life Sciences from Kyoto University.
This person is not in any teams
Astellas Pharma
42 followers
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.